On November 28, 2024, SMS welcomes representatives from the National Center for Genetic Engineering and Biotechnology (BIOTEC) and the Thai Association for Biotech Industries (ThaiBIO). The visit focused on an exclusive interview with Dr. Werawat, aiming to gather insights into the challenges, obstacles, and strategic recommendations for advancing Thailand's biotechnology sector.
This initiative aligns with Thailand's emphasis on the bioeconomy, a critical mechanism for adding value to the country's abundant agricultural raw materials. Despite its potential, the industry faces significant challenges. Addressing these issues is essential to unlocking the sector's full potential, enhancing competitiveness, and driving national development.
Dr. Werawat introduces SMS, a leading manufacturer and distributor of modified tapioca starch. This versatile ingredient finds applications across a wide range of industries, including food, pharmaceuticals, paper, construction, healthcare, and bioplastics. SMS's commitment to innovation is driven by a dedicated R&D team that consistently develops cutting-edge products and solutions to optimize performance. While the industry offers immense potential, it faces significant challenges:
To address these challenges, Dr. Werawat advocates for strong government support and collaborative partnerships. By working together, the public and private sectors can drive innovation, improve efficiency, and foster sustainable growth. To position Thailand as a global biotechnology powerhouse, Dr. Werawat proposes a strategic approach:
“Every organization should establish its own Research and Development (R&D) department with skilled personnel to enhance global competitiveness. Additionally, fostering a Business Forum as a collaborative platform for manufacturers, government agencies, and related sectors to share insights, collaborate on projects, and accelerate industry growth is crucial."
By embracing these recommendations, Thailand can overcome its current challenges and emerge as a leader in the global biotechnology landscape. This collaborative approach will unlock the full potential of biotechnology, benefiting industries, communities, and the nation's overall development.